The B3 conundrum—the radiologists' perspective

British Journal of Radiology - Tập 90 Số 1071 - 2017
Nisha Sharma1, Louise Wilkinson2, Sarah E. Pinder3
1Breast Unit, Level 1 Chancellor Wing, St James's Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK
2Department of Breast imaging, St George's Hospital, London, UK
3Department of Breast Pathology, King's College London and Guy's Hospital, London, UK

Tóm tắt

The management of B3 lesions is both controversial and complicated. There have been recent publications regarding how best to manage this heterogeneous group particularly in light of the Marmot Review and with the advent of vacuum-assisted biopsy technique. It is recognized that B3 lesions on core biopsy can be upgraded to malignancy in up to one-third of cases, but this is predominantly to ductal carcinoma in situ or low-grade invasive tumours. The upgrade rate is mainly associated with B3 lesions with epithelial atypia. This review summarizes the current management and focuses on the proposed future management of these B3 lesions.

Từ khóa


Tài liệu tham khảo

Marmot, 2013, The benefits and harms of breast cancer screening: an independent review, Br J Cancer, 108, 2205, 10.1038/bjc.2013.177

Moseholm, 2016, Health-related quality of life, anxiety and depression in the diagnostic phase of suspected cancer, and the influence of diagnosis, Health Qual Life Outcomes, 14, 80, 10.1186/s12955-016-0484-9

Purushothaman, 2016, Lesions of uncertain malignant potential in the breast (B3): what do we know?, Clin Radiol, 71, 134, 10.1016/j.crad.2015.10.008

Dupont, 1985, Risk factors for breast cancer in women with proliferative breast disease, N Engl J Med, 312, 146, 10.1056/NEJM198501173120303

Heller

Rakha, 2011, Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia, Histopathology, 58, 626, 10.1111/j.1365-2559.2011.03786.x

Pinder, 1996, The role of pre-operative diagnosis in breast cancer, Histopathology, 28, 563, 10.1046/j.1365-2559.1996.d01-465.x

Burbank, 1996, Stereotactic breast biopsy: improved tissue harvesting with the Mammotome, Am Surg, 62, 738

Preibsch, 2015, Vacuum-assisted breast biopsy with 7-gauge, 8-gauge, 9-gauge, 10-gauge, and 11-gauge needles: how many specimens are necessary?, Acta Radiol, 56, 1078, 10.1177/0284185114549224

Strachan, 2016, Outcome of a new patient pathway for managing B3 breast lesions by vacuum-assisted biopsy: time to change current UK practice?, J Clin Pathol, 69, 248, 10.1136/jclinpath-2015-203018

Houssami, 2007, Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates, Cancer, 109, 487, 10.1002/cncr.22435

Reefy, 2010, Surgical excision for B3 breast lesions diagnosed by vacuum-assisted core biopsy, Anticancer Res, 30, 2287

The Royal College of Radiologists, 2012, Ultrasound training recommendations for medical and surgical specialties, 2nd edn

Huber, 2003, Benign breast lesions: minimally invasive vacuum-assisted biopsy with 11-gauge needles—patient acceptance and effect on follow-up imaging findings, Radiology, 226, 783, 10.1148/radiol.2271011933

NICE. Image-guided vacuum-assisted excision biopsy of benign lesions. https://www.nice.org.uk/guidance/ipg156/chapter/1-guidance [last accessed April 2016]

Rakha, 2011, Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening, Int J Cancer, 129, 1417, 10.1002/ijc.25801

de Beça, 2013, Improved malignancy prediction by B3 breast lesions subclassification, Ann Diagn Pathol, 17, 434, 10.1016/j.anndiagpath.2013.05.003

Bianchi, 2011, Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy, Breast, 20, 264, 10.1016/j.breast.2010.12.003

Renshaw, 2016, Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies, Pathology, 48, 25, 10.1016/j.pathol.2015.11.015

Houssami, 2007, Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3), Br J Cancer, 96, 1253, 10.1038/sj.bjc.6603714

El-Sayed, 2008, Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening, Histopathology, 53, 650, 10.1111/j.1365-2559.2008.03158.x

Francis A, Bartlett JM, Billingham LJ, Bowden SJ, Brookes CL, Dodwell DJ, Evans AZ, Fallowfield LJ, Gaunt CH, Hanby AM, Jenkins VA. Abstract OT2-3-01: The LORIS trial: A multicentre, randomized phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ. Cancer Research. 2013 Dec 15;73(24 Supplement):OT2-3.

The Sloane Project. updated June 2016. http://www.sloaneproject.co.uk/ [last Accessed July 2016]

Zagouri, 2008, Pain in different methods of breast biopsy: emphasis on vacuum-assisted breast biopsy, Breast, 17, 71, 10.1016/j.breast.2007.07.039

Eller, 2014, Stereotactic vacuum-assisted breast biopsy (VABB)—a patients' survey, Anticancer Res, 34, 3831

Dahabreh, 2014

Holmberg, 2015, Report of the working party for higher-risk breast screening

NHS breast screening programme and Association of Breast Surgery. An audit of screen detected breast cancers for the year of screening April 2014 to March 2015. Public Health England. Published May 2016. http://www.associationofbreastsurgery.org.uk/media/63035/nhsbsp_abs_breast_screening_audit_201415_full_audit_v3.pdf [last accessed May 2016]